The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.66BCNY
997.46M · vs all stocks (USD)
Updated Nov 20, 2026
Revenue (TTM)
2.13BCNY
319.06M · vs all stocks (USD)
Updated Nov 20, 2026
Profit Margin
-50.07%
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Beta
0.5380x
vs all stocks
Updated Nov 20, 2026
52-Week Change
-38.32%
vs all stocks
Updated Nov 20, 2026
Market Capitalization
6.66BCNY
997.46M · vs all stocks (USD)
Updated Nov 20, 2026
Enterprise Value
11.98BCNY
1.80B · vs all stocks (USD)
Updated Nov 20, 2026
Forward P/E
10.67x
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Price to Sales (TTM)
3.28x
vs Specialty Industrial Machinery peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 3.13×.Updated Nov 20, 2026
Price to Book (MRQ)
2.17x
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Enterprise to Revenue
5.63x
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Enterprise to EBITDA
-22.71x
vs Specialty Industrial Machinery peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 141.46×.Updated Nov 20, 2026
Gross Margin
13.68%
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Profit Margin
-50.07%
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Operating Margin
-39.44%
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Return on Assets (TTM)
-3.70%
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Return on Equity (TTM)
-24.61%
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Revenue (TTM)
2.13BCNY
319.06M · vs all stocks (USD)
Updated Nov 20, 2026
Revenue per Share (TTM)
6.02CNYUpdated Nov 20, 2026
Quarterly Revenue Growth
-18.10%
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Gross Profit (TTM)
260.55MCNY
39.05M · vs all stocks (USD)
Updated Nov 20, 2026
EBITDA (TTM)
84.71MCNY
12.70M · vs all stocks (USD)
Updated Nov 20, 2026
Net Income (TTM)
-1.07BCNY
-159.74M · vs all stocks (USD)
Updated Nov 20, 2026
Quarterly Earnings Growth (YoY)
-54.65%
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Operating Cash Flow (TTM)
280.68MCNY
42.06M · vs all stocks (USD)
Updated Nov 20, 2026
Levered Free Cash Flow (TTM)
1.06BCNY
159.36M · vs all stocks (USD)
Updated Nov 20, 2026
5-Year Average Dividend Yield
0.34%
vs all stocks
Updated Nov 20, 2026
Payout Ratio
52.84%
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Minority Interest (Equity)
341.60MCNYFY2025 · Dec 31, 2025
Revenue
2.85BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.20BCNYFY2025 · Dec 31, 2025
Gross Profit
649.82MCNYFY2025 · Dec 31, 2025
Operating Income
-259.78MCNY
-38.93M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-801.75MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-30.45MCNYFY2025 · Dec 31, 2025
Net Income
-771.31MCNYFY2025 · Dec 31, 2025
EBIT
-531.10MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
84.71MCNYFY2025 · Dec 31, 2025
Research & Development
333.62MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
241.50MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
29.28MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.03MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
270.65MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-2.02CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-2.02CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
384.57MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
384.57MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-771.31MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-5.51MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-583.10MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-753.03MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
798.36MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-771.31MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
296.59MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
300.12MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-408.50MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-169.93MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-32.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
186.01MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-2.23MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-18.15MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
5.11BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-4.80BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-317.39MCNYFY2025 · Dec 31, 2025
Other Financing Charges
636.02MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
629.62MCNYFY2025 · Dec 31, 2025
Shares Outstanding
382.96MSharesUpdated Nov 20, 2026
Float Shares
275.15MSharesUpdated Nov 20, 2026
% Held by Insiders
27.49%
vs all stocks
Updated Nov 20, 2026
% Held by Institutions
3.36%
vs all stocks
Updated Nov 20, 2026
Total Cash (MRQ)
470.16MCNY
70.46M · vs all stocks (USD)
Updated Nov 20, 2026
Total Cash per Share (MRQ)
1.24CNYUpdated Nov 20, 2026
Total Debt (MRQ)
5.14BCNY
770.52M · vs all stocks (USD)
Updated Nov 20, 2026
Total Debt to Equity (MRQ)
1.48x
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Current Ratio (MRQ)
1.15x
vs Specialty Industrial Machinery peers
Updated Nov 20, 2026
Book Value per Share (MRQ)
8.42CNYUpdated Nov 20, 2026
Total Assets
14.05BCNY
2.11B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
8.41BCNYFY2025 · Dec 31, 2025
Total Liabilities
10.21BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
5.64BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
3.36BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
6.85BCNYFY2025 · Dec 31, 2025
Cash
820.09MCNYFY2025 · Dec 31, 2025
Cash Equivalents
185.66MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.01BCNYFY2025 · Dec 31, 2025
Accounts Receivable
2.86BCNYFY2025 · Dec 31, 2025
Inventory
3.43BCNYFY2025 · Dec 31, 2025
Accounts Payable
1.49BCNYFY2025 · Dec 31, 2025
Short-term Debt
4.00BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
171.35MCNYFY2025 · Dec 31, 2025
Long-term Debt
2.20BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
834.74MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
382.96MCNYFY2025 · Dec 31, 2025
Retained Earnings
52.99MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.84BCNY
575.35M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
115.89MCNYFY2025 · Dec 31, 2025
52-Week Low
17.04CNYUpdated Nov 20, 2026
52-Week High
38.21CNYUpdated Nov 20, 2026
52-Week Change
-38.32%
vs all stocks
Updated Nov 20, 2026
Beta
0.5380x
vs all stocks
Updated Nov 20, 2026
50-Day MA
21.19CNYUpdated Nov 20, 2026
200-Day MA
25.39CNYUpdated Nov 20, 2026
Avg 10-Day Volume
15.07MSharesUpdated Nov 20, 2026
Avg 30-Day Volume
23.52MSharesUpdated Nov 20, 2026
Diluted EPS (TTM)
-2.77CNYUpdated Nov 20, 2026
4 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -39.4%, lower than 95% of its Specialty Industrial Machinery peers (median 10%)Significant
Elevated Leverage on Three DenominatorsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone
Elevated Leverage on Three DenominatorsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone